AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,167,843 | -28.2% | 4,272,203 | -44.5% | 0.98% | -9.3% |
| Q1 2023 | $14,152,936 | -4.3% | 7,691,813 | -1.2% | 1.08% | +13.2% |
| Q4 2022 | $14,785,834 | +30.7% | 7,782,018 | +47.2% | 0.96% | +30.9% |
| Q3 2022 | $11,312,000 | -22.3% | 5,286,088 | +2.8% | 0.73% | +0.3% |
| Q2 2022 | $14,554,000 | -19.7% | 5,142,855 | +18.3% | 0.73% | -9.0% |
| Q1 2022 | $18,124,000 | -14.4% | 4,346,327 | +6.6% | 0.80% | +7.7% |
| Q4 2021 | $21,162,000 | +10.0% | 4,077,509 | +38.8% | 0.74% | +22.9% |
| Q3 2021 | $19,236,000 | +61.5% | 2,936,791 | +63.7% | 0.61% | +79.3% |
| Q2 2021 | $11,909,000 | – | 1,793,500 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 2,150,000 | $34,465,000 | 4.59% |
| Eversept Partners, LP | 258,360 | $4,141,511 | 0.57% |
| Alphabet Inc. | 698,262 | $11,193,000 | 0.52% |
| DAFNA Capital Management LLC | 64,235 | $1,030,000 | 0.30% |
| Cormorant Asset Management, LP | 479,988 | $7,694,000 | 0.29% |
| Opaleye Management Inc. | 60,000 | $962,000 | 0.19% |
| Granahan Investment Management | 330,747 | $5,302,000 | 0.19% |
| Artal Group S.A. | 400,000 | $6,412,000 | 0.18% |
| Burrage Capital Management LLC | 15,006 | $241,000 | 0.17% |
| MPM BioImpact LLC | 39,740 | $637,000 | 0.17% |